In accordance with the provisions of Article 66 of the Securities Market Act and with the Rules of the Ljubljana Stock Exchange, Lek Pharmaceuticals d.d. hereby announces
that Lek d.d. received on 21 October 2002 a notification from the Pension Fund Management d.d., communicated in agreement with the shareholders indicated hereinafter, stating that the Pension Fund Management d.d., the Slovenian Restitution Fund d.d., the National Finance Corporation (on behalf of NFD 1 Investment Fund p.l.c.) and the Triglav Fund Management Company Ltd. (on behalf of Triglav Steber Investment Fund d.d.) have made a decision to accept the revised public offer for the purchase of the shares of Lek d.d. at a price of SIT 105,000 per share, made by the company Servipharm AG and published in the Delo newspaper on 19 October 2002.